TasPĀ® Update

Presenter:
Dr. Julio Montaner
Executive Director and Physician-in-Chief, BC Centre for Excellence in HIV/AIDS
Head, HIV/AIDS Program, St. Paul’s Hospital, Providence Health Care
UBC and St. Paul’s Foundation Chair in AIDS Research and UBC-Killam Professor, Faculty of Medicine, University of British Columbia
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025